September 15, 2010 โ The U.S. Food and Drug Administration (FDA) has extended the time to complete its review of ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
September 8, 2010 โ The increased effectiveness of ticagrelor (Brilinta) in overcoming high platelet reactivity as ...
September 7, 2010 - With increasing rates of patients with atrial fibrillation program suffering from severe ...
September 2, 2010 - Women and men with a 10-year cardiovascular disease risk of 5 percent or more and normal ...
August 30, 2010 โ According to the results of a late-breaking analysis involving more than 200 000 patients in ...
August 18, 2010 - The U.S. Food and Drug Administration (FDA) today proposed to withdraw approval of the drug ...
August 2, 2010 โ Research by an international team of scientists, including a University of California (UC) ...
July 29, 2010 โ A new, highly anticipated antiplatelet drug was recommended yesterday for final approval by the U ...
July 26, 2010 โ The U.S. Food and Drug Administration (FDA) approved the first generic version of Lovenox ...
July 26, 2010 โ A new three-in-one combination drug has been approved by the U.S. Food and Drug Administration ...
July 22, 2010 โ Accumetrics Inc., Daiichi Sankyo Inc., and Eli Lilly and Co. recently announced that they have ...
July 13, 2010 โ AstraZeneca recently announced that the U.S. District Court has found that the substance patent ...
July 1, 2010 โ Two medical companies say they will work with physicians to further investigate ways to manage ...
July 1, 2010 โ The U.S. Food and Drug Administration (FDA) recently added a warning to the information on ...
June 24, 2010 โ The first cohort of patients was fully enrolled this week in a clinical study of a new drug meant ...